Launched in May 2020, the Index offers pharmaceutical and biotech companies an opportunity to showcase, benchmark and evaluate the quality of their communications and advocacy with patient groups. The aim is to celebrate as many companies that meet the mark, so we can raise the bar across the industry. There are no costs involved – entering the Index is completely free for everyone.
The Index will evaluate the highest standards, based on best practice, of partnerships in communications and advocacy between pharmaceutical, biotech and patient communities.
Companies are offered the opportunity to submit entries to the Index. In return, they will be recognised amongst their industry peers and patient organisations, as well as receive an exclusive insights report from OVID Health. Entries for the 2020 Index are now closed, but you can pre-register for 2021.
The final results have been announced (check out our news page for the details) and all entrants will have the opportunity to profile their involvement with the Index through their own external and internal channels.